EcoDrugPlus

Arginine Vasopressin Receptor 2

Ensembl ID : ENSOJAG00000022751
Gene Symbol: AVPR2
1 Cross references
178 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSOJAG00000013097
Gene Symbol: AVPR2
1 Cross references
148 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSOJAG00000019766
Gene Symbol: AURKA
1 Cross references
232 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSOJAG00000011520
Gene Symbol: AURKB
1 Cross references
204 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSOJAG00000017151
Gene Symbol: AURKB
1 Cross references
204 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSOJAG00000011345
Gene Symbol: BACE1
1 Cross references
218 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSOJAG00000022891
Gene Symbol: BDKRB2
1 Cross references
161 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSOJAG00000022887
Gene Symbol: BDKRB2
1 Cross references
243 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSOJAG00000022885
Gene Symbol: BDKRB2
1 Cross references
243 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1s Subunit, A

Ensembl ID : ENSOJAG00000009581
Gene Symbol: CACNA1SA
1 Cross references
195 Possible Orthologues:

Calcium Channel, Voltage-Dependent, N Type, Alpha 1b Subunit, A

Ensembl ID : ENSOJAG00000003001
Gene Symbol: CACNA1BA
1 Cross references
219 Possible Orthologues:

Calcium Channel, Voltage-Dependent, P/q Type, Alpha 1a Subunit, B

Ensembl ID : ENSOJAG00000004472
Gene Symbol: CACNA1AB
1 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).